By Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches features of LifeSciVC When your team’s priority is to execute a well-formed …
Biotech Newsroom
-
-
Tokyo-headquartered Elix and the Graduate School of Life Sciences at Tohoku University signed a joint research agreement aimed at advancing drug discovery using AI technologies. Company …
-
The takeover of Shire is the largest acquisition in Takeda’s history. Under the agreement, Takeda will pay US$66, per share US$30.33 in cash and 0.839 Takeda …
-
Smoking causes cancer. That may be enough for some people, but for those interested in what happens in between, what follows is one explanation. Upon inhalation …
-
Bioinformatics
Unlocking data in Klebsiella lysogens to predict capsular type-specificity of phage depolymerases
A comprehensive profiling of prophage-encoded depolymerases targeting Klebsiella To gather a collection of prophages with labeled KL type, all Klebsiella genomes were first downloaded from the …
-
Gene Therapy
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
The results from this study demonstrate that monoclonal expansion of J∆NI8 HSV-1 vectors can result in genetic mutations, some of which can significantly alter the functional …
-
Breast cancer is not only a health crisis – it also disrupts work, income, and identity for thousands of Australians each year. Beyond the physical toll, …
-
Word Count: 2,602 words, Reading Time: 12 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …
-
Dementia care is one of the most challenging and complex areas of healthcare. With the number of people affected by this debilitating condition steadily rising, there …
-
On September 9, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued numerous untitled letters as part of the agency’s …